Abstract
Sex steroids, including testosterone, play a major role in determining peak bone mass in mammals and the subsequent loss of total bone mass with advancing age. Testosterone, and its active metabolite dihydrotestosterone (DHT), bind with high affinity to the androgen receptor (AR), a member of the nuclear hormone receptor superfamily. These receptors function as transcription factors, binding together with accessory proteins to specific DNA response elements in the promoters of androgen responsive genes. To further characterize AR function in a model species of relevance to bone and pharmaceutical research, we cloned a partial canine AR from a canine kidney cDNA library and then cloned the remaining 5′ segment by PCR from canine ventral prostate cDNA. The complete sequence obtained was 3577 bp. This sequence contained a single open reading frame of 2721 bp, potentially encoding a protein of 907 amino acids with a predicted molecular weight of 98.7 kD. Sequence analysis of the protein encoded by this open reading frame reveals that the modular domains providing the DNA binding and ligand binding functions are identical to those reported for eight other mammalian ARs. Northern analysis of poly-A+ RNA from ventral prostate revealed three very low abundance transcripts of approximately 9 kb and RT-PCR analysis showed relatively high expression of AR in canine ventral prostate, testis, and kidney, with lower levels detectable in spleen, skeletal muscle, heart, and liver. Competition binding studies using 3H-DHT as ligand demonstrated specific displacement by DHT, testosterone, and the anabolic steroid stanozolol, with IC50 values of 1.3, 2.5 and 3.8 nM, respectively. Binding of DHT also resulted in the stimulation of an androgen responsive-luciferase reporter following cotransfection with the canine AR into 293 cells. Immunohistochemistry using an antibody directed to the C-terminal 19 amino acids of the human AR showed strong staining of the secretory epithelial cells in canine ventral prostate. Together, these data indicate that we have cloned the canine AR and that its functional DNA binding and ligand binding domains are absolutely conserved with those reported for eight other species.
Similar content being viewed by others
References
Raisz LG: Physiology and pathophysiology of bone remodeling. Clin Chem 45: 1353–1358, 1999
Hofbauer LC, Khosla S: Androgen effects on bone metabolism: Recent progress and controversies. Eur J Endocrinol 140: 271–286, 1999
Kasra M, Grynpas MD: The effects of androgens on the mechanical properties of primate bone. Bone 17: 265–270, 1995
Jackson JA: Osteoporosis in men. In: M.J. Favus (ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Raven Press, New York, 1993, pp 255–258
Baran DT, Bergfeld MA, Teitelbaum SL, Avioli LV: Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male. Calcified Tiss Int 25: 103–106, 1978
Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E: Longterm effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 82: 2386–2390, 1997
Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S: Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106: 1553–1560, 2000
Brinkmann AO, Blok LJ, de Ruiter PE, Doesburg P, Steketee K, Berrevoets CA, Trapman J: Mechanisms of androgen receptor activation and function. J Steroid Biochem Mol Biol 69: 307–313, 1999
Zhou Z-X, Wong C-I, Sar M, Wilson EM: The androgen receptor: An overview. Recent Prog Hormone Res 49: 249–274, 1994
MacLean HE, Warne GL, Zajac JD: Localization of functional domains in the androgen receptor. J Steroid Biochem Molec Biol 62: 233–242, 1997
Chang C, Saltzman A, Yeh S, Young W, Keller E, Lee H-J, Wang C, Mizokami A: Androgen receptor: An overview. Crit Rev Eukary Gene Express 5: 97–125, 1995
Thiede MA, Smock SL, Petersen DN, Grasser WA, Thompson DD, Nishimoto SK: Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology 135: 929–937, 1994
Chang C, Kokontis J, Liao S: Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 85: 7211–7215, 1988
Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM: Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240: 327–330, 1988
Faber PW, King A, van Rooij HC, Brinkmann AO, de Both NJ, Trapman J: The mouse androgen receptor. Functional analysis of the protein and characterization of the gene. Biochem J 278: 269–278, 1991
He WW, Fischer LM, Sun S, Bilhartz DL, Zhu X, Young CY-F, Kelley DB, Tindall DJ: Molecular cloning of androgen receptors from divergent species with a polymerase chain reaction technique: Complete cDNA sequence of the mouse androgen receptor and isolation of androgen receptor cDNA probes from dog, guinea pig, and clawed frog. Biochem Biophys Res Comm 171: 697–704, 1990
Tan JA, Joseph DR, Quarmby VE, Lubahn DB, Sar M, French FS, Wilson EM: The rat androgen receptor: Primary structure, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein. Mol Endocrinol 2: 1276–1285, 1988
Liao S, Witte D, Schilling K, Chang C: The use of a hydroxylapatite-filter steroid receptor assay method in the study of the modulation of androgen receptor interaction. J Steroid Biochem 20: 11–17, 1984
Clark C: Staining Procedures, 4th ed. Williams and Wilkins, Baltimore, MD, 1981, p 121
Shibuya H, Nonneman DJ, Huang TH-M, Ganjam VK, Mann FA, Johnson GS: Two polymorphic microsatellites in a coding segment of the canine androgen receptor gene. Anim Genet 24: 345–348, 1993
Cato ACB, Henderson D, Ponta H: The hormone response element of the mouse mammary tumor virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. EMBO J 6: 363–368, 1987
Riegman PHJ, Vlietstra RJ, van der Korput JAGM, Brinkmann AO, Trapman J: The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol Endocrinol 5: 1921–1930, 1991
Rennie PS, Bruchovsky N, Leco KJ, Sheppard PC, McQueen SA, Cheng H, Snoek R, Hamel A, Bock ME, MacDonald BS, Nickel BE, Chang C, Liao S, Cattini PA, Matusik RJ: Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol 7: 23–36, 1993
Claessens F, Alen P, Devos A, Peeters B, Verhoeven G, Rombauts W: The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors. J Biol Chem 271: 19013–19016, 1996
Zhou Z, Corden JL, Brown TR: Identification and characterization of a novel androgen response element composed of a direct repeat. J Biol Chem 272: 8227–8235, 1997
Choong CS, Wilson EM: Trinucleotide repeats in the human androgen receptor: A molecular basis for disease. J Mol Endocrinol 21: 235–257, 1998
Edwards SM, Badzioch MD, Minter R, Hamoudi R, Collins N, Ardern-Jones A, Dowe A, Osborne S, Kelly J, Shearer R, Easton DF, Saunders GF, Dearnaley DP, Eeles RA: Androgen receptor polymorphisms: Association with prostate cancer risk, relapse, and overall survival. Int J Cancer 84: 458–465, 1999
LaSpada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH: Androgen receptor gene mutations in X-linked spinal and bulbar muscular dystrophy. Nature 352: 77–79, 1991
Lim HN, Chen H, McBride S, Dunning AM, Nixon RM, Hughes IA, Hawkins JR: Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males. Hum Mol Genet 9: 829–834, 2000
Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G, Pinsky L: Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular dystrophy. Nat Genet 5: 184–188, 1993
Chamberlain NL, Driver ED, Miesfeld RL: The length and location of CAG trinucleotide repeats in the androgen receptor Nterminal domain affect transactivation function. Nucleic Acids Res 22: 3181–3186, 1994
Choong CS, Kemppainen JA, Zhou Z-X, Wilson EM: Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol 10: 1527–1535, 1996
Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, Coetzee GA: Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet 9: 267–274, 2000
Miyamoto KK, McSherry SA, Dent GA, Sar M, Wilson EM, French FS, Sharief Y, Mohler JL: Immunohistochemistry of the androgen receptor in human benign and malignant prostate tissue. J Urol 149: 1015–1019, 1993
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lu, B., Smock, S.L., Castleberry, T.A. et al. Molecular cloning and functional characterization of the canine androgen receptor. Mol Cell Biochem 226, 129–140 (2001). https://doi.org/10.1023/A:1012752107129
Issue Date:
DOI: https://doi.org/10.1023/A:1012752107129